Emmaus Life Sciences, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Emmaus Life Sciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $821K, a 3321% increase year-over-year.
  • Emmaus Life Sciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $18K, a 97.7% decline year-over-year.
  • Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2023 was $3.54M.
  • Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2022 was -$6.59M, a 7.47% decline from 2021.
  • Emmaus Life Sciences, Inc. annual Operating Income (Loss) for 2021 was -$6.13M, a 19050% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $18K $821K +$797K +3321% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 -$779K $582K -$2.74M -82.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-10
Q1 2024 $1.97M -$2.74M -$1.58M -135% Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-10
Q4 2023 $3.54M $1.36M +$2.77M Oct 1, 2023 Dec 31, 2023 10-K 2024-07-03
Q3 2023 $767K $24K +$684K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 $83K $3.33M +$4.77M Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-10
Q1 2023 -$4.68M -$1.17M +$1.9M +62% Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-10
Q4 2022 -$6.59M -$1.42M +$3.55M +71.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-07-03
Q3 2022 -$10.1M -$660K -$629K -2029% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$9.5M -$1.44M -$1.92M -398% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$7.58M -$3.07M -$1.45M -90% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$6.13M -$4.97M -$5.33M -1475% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$802K -$31K -$39K -488% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$763K $483K +$2.02M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$2.78M -$1.62M -$2.75M -242% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$32K $361K -$339K -48.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $307K $8K +$4.06M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$3.75M -$1.54M -$1.65M -1423% Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-01
Q1 2020 -$2.1M $1.13M +$2.42M Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-01
Q4 2019 -$4.51M $700K +$3.38M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-08-10
Q3 2019 -$7.89M -$4.05M -$1.92M -89.9% Jul 1, 2019 Sep 30, 2019 10-Q 2021-08-26
Q2 2019 -$5.98M $116K +$2.87M Apr 1, 2019 Jun 30, 2019 10-Q 2021-08-26
Q1 2019 -$8.85M -$1.28M +$1.35M +51.3% Jan 1, 2019 Mar 31, 2019 10-Q 2021-08-26
Q4 2018 -$10.2M -$2.68M +$74.1K +2.69% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-14
Q3 2018 -$10.3M -$2.13M +$563K +20.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$10.8M -$2.76M -$1.2M -77.4% Apr 1, 2018 Jun 30, 2018 8-K/A 2019-08-14
Q1 2018 -$9.64M -$2.63M -$1.21M -85.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$8.42M -$2.76M -$1.32M -91.9% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$7.1M -$2.69M -$1.05M -63.9% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-11
Q2 2017 -$6.05M -$1.55M -$745K -92.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$5.31M -$1.42M -$730K -106% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$4.58M -$1.44M -$811K -130% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
Q3 2016 -$3.77M -$1.64M -$1.11M -207% Jul 1, 2016 Sep 30, 2016 10-K 2017-12-29
Q2 2016 -$2.66M -$809K -$253K -45.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$2.41M -$690K +$90.1K +11.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$2.5M -$625K +$155K +19.8% Oct 1, 2015 Dec 31, 2015 10-Q/A 2017-03-30
Q3 2015 -$2.65M -$535K +$363K +40.5% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-22
Q2 2015 -$3.01M -$556K +$459K +45.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$3.47M -$780K +$161K +17.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$3.63M -$779K +$185K +19.2% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-17
Q3 2014 -$3.82M -$898K +$300K +25.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-01-05
Q2 2014 -$4.12M -$1.01M +$165K +14% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$4.28M -$941K +$184K +16.4% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-05-18
Q4 2013 -$4.47M -$964K -$265K -37.9% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 -$4.2M -$1.2M -$163K -15.8% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-29
Q2 2013 -$4.04M -$1.18M -$26K -2.25% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$4.01M -$1.12M +$209K +15.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$4.22M -$699K +$585K +45.6% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-13
Q3 2012 -$4.81M -$1.03M -$243K -30.8% Jul 1, 2012 Sep 30, 2012 10-K 2013-12-23
Q2 2012 -$4.56M -$1.15M +$296K +20.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.86M -$1.33M +$173K +11.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$5.03M -$1.28M +$260K +16.8% Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-02-22
Q3 2011 -$5.29M -$791K Jul 1, 2011 Sep 30, 2011 10-K 2013-01-15
Q2 2011 -$1.45M +$10.2K +0.7% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-11
Q1 2011 -$1.51M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$1.54M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q2 2010 -$1.46M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.